Phase Ii Dose-Response Clinical Trial Using Febuxostat (Tmx-67), A Novel-Type Xanthine Oxidase/Xanthine Dehydrogenase Inhibitor, For Gout And Hyperuricemia.
ARTHRITIS AND RHEUMATISM（2003）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined